Several other analysts also recently commented on the stock. Barclays set a €27.50 ($32.74) target price on shares of AXA and gave the stock a buy rating in a report on Wednesday, October 25th. Deutsche Bank set a €27.50 ($32.74) target price on shares of AXA and gave the stock a buy rating in a report on Monday, October 9th. Kepler Capital Markets set a €29.80 ($35.48) target price on shares of AXA and gave the stock a buy rating in a report on Thursday, September 28th. Royal Bank of Canada set a €28.00 ($33.33) target price on shares of AXA and gave the stock a buy rating in a report on Wednesday, September 13th. Finally, Baader Bank set a €27.00 ($32.14) target price on shares of AXA and gave the stock a buy rating in a report on Friday, November 3rd. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. The company has an average rating of Buy and a consensus target price of €27.68 ($32.95).
AXA (CS) opened at €26.86 ($31.98) on Tuesday. AXA has a 12-month low of €21.81 ($25.96) and a 12-month high of €27.04 ($32.19). The company has a market cap of $65,140.00 and a PE ratio of 11.43.
TRADEMARK VIOLATION WARNING: “JPMorgan Chase & Co. Analysts Give AXA (CS) a €29.20 Price Target” was reported by Stock Observer and is owned by of Stock Observer. If you are accessing this report on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.thestockobserver.com/2018/01/13/jpmorgan-chase-29-20-price-target.html.
AXA SA (AXA) is a France-based holding company engaged in the business of financial protection. The Company’s segments include Life & Savings, Property & Casualty, Asset Management , Banking and Holding companies. The Life & Savings segment’s products include a range of investment and savings products, as well as Protection and Health products.
Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.